CA2250583C - Process for the preparation of n-methyl-d-phenylalanyl-n-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide - Google Patents

Process for the preparation of n-methyl-d-phenylalanyl-n-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide Download PDF

Info

Publication number
CA2250583C
CA2250583C CA002250583A CA2250583A CA2250583C CA 2250583 C CA2250583 C CA 2250583C CA 002250583 A CA002250583 A CA 002250583A CA 2250583 A CA2250583 A CA 2250583A CA 2250583 C CA2250583 C CA 2250583C
Authority
CA
Canada
Prior art keywords
amino
bis
hydroxy
protected
difluorononane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002250583A
Other languages
English (en)
French (fr)
Other versions
CA2250583A1 (en
Inventor
Duane E. Rudisill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of CA2250583A1 publication Critical patent/CA2250583A1/en
Application granted granted Critical
Publication of CA2250583C publication Critical patent/CA2250583C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002250583A 1996-03-26 1997-02-25 Process for the preparation of n-methyl-d-phenylalanyl-n-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide Expired - Fee Related CA2250583C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62472196A 1996-03-26 1996-03-26
US08/624,721 1996-03-26
PCT/US1997/002869 WO1997035874A1 (en) 1996-03-26 1997-02-25 Process for the preparation of n-methyl-d-phenylalanyl-n-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide

Publications (2)

Publication Number Publication Date
CA2250583A1 CA2250583A1 (en) 1997-10-02
CA2250583C true CA2250583C (en) 2003-01-14

Family

ID=24503070

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002250583A Expired - Fee Related CA2250583C (en) 1996-03-26 1997-02-25 Process for the preparation of n-methyl-d-phenylalanyl-n-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide

Country Status (13)

Country Link
EP (1) EP1012165A1 (xx)
JP (1) JP2000507267A (xx)
KR (1) KR20000004991A (xx)
CN (1) CN1121410C (xx)
AR (1) AR006366A1 (xx)
AU (1) AU710040B2 (xx)
BR (1) BR9708369A (xx)
CA (1) CA2250583C (xx)
IL (1) IL126071A (xx)
NO (1) NO984490L (xx)
NZ (1) NZ331432A (xx)
WO (1) WO1997035874A1 (xx)
ZA (1) ZA972506B (xx)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503203A1 (en) * 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors

Also Published As

Publication number Publication date
AU2055097A (en) 1997-10-17
CN1214691A (zh) 1999-04-21
JP2000507267A (ja) 2000-06-13
EP1012165A1 (en) 2000-06-28
WO1997035874A1 (en) 1997-10-02
NO984490D0 (no) 1998-09-25
NO984490L (no) 1998-09-25
AU710040B2 (en) 1999-09-09
IL126071A (en) 2003-06-24
ZA972506B (en) 1997-09-26
CN1121410C (zh) 2003-09-17
NZ331432A (en) 2000-03-27
AR006366A1 (es) 1999-08-25
CA2250583A1 (en) 1997-10-02
IL126071A0 (en) 1999-05-09
KR20000004991A (ko) 2000-01-25
BR9708369A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
Webb et al. Conformationally restricted arginine analogs
EP0201743B1 (en) Dipeptide derivatives of fatty acids, process for preparing them, pharmaceutical composition and use
FI86192C (fi) Stereoselektiv foerfarande foer framstaellning av omaettad laktoner.
EP0618223A2 (en) Peptides inhibiting interleukin 1-bêta release useful as antiinflammatory agents
Kurokawa et al. Synthetic studies on antifungal cyclic peptides, echinocandins. Stereoselective total synthesis of echinocandin D via a novel peptide coupling
JPH0355480B2 (xx)
FI95272B (fi) Menetelmä terapeuttisesti käyttökelpoisen sykloheksyylidifluoroepeptidin valmistamiseksi
EP0863916B1 (en) Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
CA2250583C (en) Process for the preparation of n-methyl-d-phenylalanyl-n-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide
US5739354A (en) Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide
JPH0386870A (ja) レニン阻害剤としてのアミノ―置換された複素還式化合物
US6265381B1 (en) Orally-active elastase inhibitors
FI64349B (fi) Foerfarande foer framstaellning av ett terapeutiskt anvaendbart l-pyroglutamyl-l-histidyl-glycin och dess salter
ZA200300080B (en) Thrombin inhibitors comprising an aminoisoquinoline group.
US5166154A (en) Imidazo[1,2-a]piperazines
MXPA98007882A (en) Procedure for the preparation of n-methyl-d-phenylalanil-n- (1- (3 - ((aminoiminomethyl) amino) propyl) -3,3-difluoro-2-oxohexil) -l-prolinam
JP2002532466A (ja) α−ヒドロキシ−β−アミノ酸およびアミド誘導体の合成のための方法
KR20030033001A (ko) 5-페닐펜타노일-ala-argl-ala-[2-(3-아미노-2-옥소피롤리딘-1-일)프로피오닐]-ala-arg-ala-4-아미노페닐아세트아미드의 제조방법
EP0832879A1 (en) Process for preparing intermediates for thrombin inhibitors
CA1321676C (en) Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
JP2004083427A (ja) 環状ヘキサペプチド及びプロテアソーム阻害剤
Kinoshita et al. Synthesis of a peptide lactone, N-(3-hydroxypicolinyl)-threonyl-D-leucyl-prolylsarcosyl-leucyl-alanyl-alanine threonine lactone.
KR820001616B1 (ko) 테트라펩타이드의 제조방법
EP0786470A1 (en) Peptide compound
CA2049390A1 (en) Novel peptide derivatives and their pharmaceutical use

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20050225